Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfunction in vivo?
Analysis ID: SDA-2026-04-16-gap-debate-20260410-113045-27c7b314 | Domain: neurodegeneration | Status: completed | Created: 2026-04-16T07:14:03.177314
Knowledge Graph: 2 edges — View JSON
Top Hypotheses (2 total)
#1 Sequential TRPML1 Activation Following Autophagy Priming
0.575
MCOLN1 (TRPML1), ATG7
# Sequential TRPML1 Activation Following Autophagy Priming: A Mechanistic Framework for Therapeutic Intervention in Neurodegeneration
## Hypothesis Statement
The proposed hypothesis posits that **au
#2 TRPML1-PINK1/Parkin Axis Coordinates Mitophagy with Lysosomal Biogenesis
0.560
MCOLN1, PINK1, PARK2, TFEB, LRRK2
TRPML1 Enhancement Couples PINK1/Parkin-Mediated Mitophagy to TFEB-Dependent Lysosomal Replenishment in Parkinson's Disease. PINK1/Parkin-mediated mitophagy generates TFEB-activating signals that are